2018
DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 11th Edition.
DeVita VT, Lawrence TS, Rosenberg SA, (Eds) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 11th Edition. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018.Books
2017
Progress in the Treatment of Hodgkin’s Lymphoma
Longo DL, DeVita VT. Progress in the Treatment of Hodgkin’s Lymphoma. New England Journal Of Medicine 2017, 378: 392-394. PMID: 29224505, DOI: 10.1056/nejme1715141.Peer-Reviewed Original Research
2016
Vincent T. DeVita on His New Book, "The Death of Cancer," and the Current State of Cancer Care.
DeVita V. Vincent T. DeVita on His New Book, "The Death of Cancer," and the Current State of Cancer Care. Oncology 2016, 30: 210. PMID: 26984212.Peer-Reviewed Original ResearchA CONVERSATION WITH VINCENT DEVITA, MD. No Truce Sought in Cancer War: 'We Want to Cure This Disease'.
DeVita V, Wehrwein P. A CONVERSATION WITH VINCENT DEVITA, MD. No Truce Sought in Cancer War: 'We Want to Cure This Disease'. Managed Care 2016, 25: 39-41. PMID: 26882628.Peer-Reviewed Original Research
2015
Cancer's final act?
DeVita V. Cancer's final act? The New Scientist 2015, 228: 26-27. DOI: 10.1016/s0262-4079(15)31556-6.Peer-Reviewed Original ResearchThe Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer is Winnable--and How We Can Get There
DeVita VT, DeVita-Raeburn E. The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer is Winnable--and How We Can Get There. New York, NY, Sarah Crighton Books at Farrar, Straus and Giroux, November 3, 2015.Peer-Reviewed Original Research
2014
Clinical cancer research: the past, present and the future
DeVita VT, Eggermont AM, Hellman S, Kerr DJ. Clinical cancer research: the past, present and the future. Nature Reviews Clinical Oncology 2014, 11: 663-669. PMID: 25245981, DOI: 10.1038/nrclinonc.2014.153.Peer-Reviewed Original ResearchTreatment of Hodgkin Lymphoma: A 50-Year Perspective
Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, DeVita VT. Treatment of Hodgkin Lymphoma: A 50-Year Perspective. Journal Of Clinical Oncology 2014, 32: 163-168. PMID: 24441526, DOI: 10.1200/jco.2013.53.1194.Peer-Reviewed Original ResearchAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBleomycinClinical Trials as TopicCyclophosphamideDacarbazineDisease-Free SurvivalDoxorubicinEtoposideEuropeHistory, 20th CenturyHodgkin DiseaseHumansMechlorethamineNeoplasm StagingPositron-Emission TomographyPrednisoneProcarbazineSurvival RateTomography, X-Ray ComputedTreatment OutcomeVinblastineVincristine
2013
Emil Frei III: A Personal Remembrance
Canellos G, DeVita V. Emil Frei III: A Personal Remembrance. The Oncologist 2013, 18: 892-893. PMCID: PMC3720644, DOI: 10.1634/theoncologist.2013-0214.Peer-Reviewed Original Research
2011
Correction: Hematology in 2010: New therapies and standard of care in oncology
DeVita V, Canellos G. Correction: Hematology in 2010: New therapies and standard of care in oncology. Nature Reviews Clinical Oncology 2011, 8: 384-384. DOI: 10.1038/nrclinonc.2011.93.Peer-Reviewed Original Research
2010
Focus issue on biomarkers
Hutchinson L, DeVita V. Focus issue on biomarkers. Nature Reviews Clinical Oncology 2010, 7: 295-295. PMID: 20517335, DOI: 10.1038/nrclinonc.2010.70.Peer-Reviewed Original ResearchA breakthrough in Hodgkin's disease
DeVita V. A breakthrough in Hodgkin's disease. Nature Reviews Clinical Oncology 2010, 7: 179-179. PMID: 20354537, DOI: 10.1038/nrclinonc.2010.36.Peer-Reviewed Original ResearchBreast cancer screening and mortality
DeVita V. Breast cancer screening and mortality. Nature Reviews Clinical Oncology 2010, 7: 65-65. PMID: 20118972, DOI: 10.1038/nrclinonc.2009.232.Peer-Reviewed Original ResearchConflict of interest disclosures
Hutchinson L, DeVita V. Conflict of interest disclosures. Nature Reviews Clinical Oncology 2010, 7: 1-1. PMID: 20029440, DOI: 10.1038/nrclinonc.2009.215.Peer-Reviewed Original Research
2009
The NIH entitlement program
DeVita V. The NIH entitlement program. Nature Reviews Clinical Oncology 2009, 6: 613-613. PMID: 19861989, DOI: 10.1038/nrclinonc.2009.164.Peer-Reviewed Original ResearchWe have met the enemy and he is us!
DeVita V. We have met the enemy and he is us! Nature Reviews Clinical Oncology 2009, 6: 493-493. PMID: 19707237, DOI: 10.1038/nrclinonc.2009.89.Peer-Reviewed Original ResearchThe most important news at ASCO 2009
DeVita V. The most important news at ASCO 2009. Nature Reviews Clinical Oncology 2009, 6: 371-371. PMID: 19561629, DOI: 10.1038/nrclinonc.2009.93.Peer-Reviewed Original ResearchThe struggles of cancer centers
DeVita V. The struggles of cancer centers. Nature Reviews Clinical Oncology 2009, 6: 241-241. PMID: 19390544, DOI: 10.1038/nrclinonc.2009.51.Peer-Reviewed Original ResearchOff-label use of approved drugs
DeVita V. Off-label use of approved drugs. Nature Reviews Clinical Oncology 2009, 6: 181-181. PMID: 19333219, DOI: 10.1038/nrclinonc.2009.41.Peer-Reviewed Original ResearchNews the public should rely on
DeVita V. News the public should rely on. Nature Reviews Clinical Oncology 2009, 6: 59-59. PMID: 19180108, DOI: 10.1038/ncponc1301.Peer-Reviewed Original Research